resveratrol has been researched along with Blood Clot in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 5 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalho, F; Correia-da-Silva, M; Cunha-Ribeiro, LM; Duarte, B; Marques, F; Pinto, MM; Sousa, E | 1 |
| Chiang, YC; Kang, YF; Tsai, MC; Wang, HC; Wu, CC; Wu, YS | 1 |
| Grużewska, K; Gul-Hinc, S; Jankowska-Kulawy, A; Michno, A; Ronowska, A; Zyśk, M | 1 |
| Altucci, L; Bucci, T; Carafa, V; Carrizzo, A; Ciccarelli, M; Damato, A; Di Nonno, F; Di Pietro, P; Frati, G; Giudice, V; Giugliano, G; Iside, C; Izzo, R; Nebbioso, A; Puca, AA; Sciarretta, S; Scioli, M; Selleri, C; Serio, B; Storto, M; Trimarco, B; Trimarco, V; Valenti, V; Vecchione, C; Venturini, E | 1 |
| Jankauskas, SS; Mone, P; Santulli, G | 1 |
| Albadawi, DAI; Chaggar, V; Dash, PR; Patel, K; Patra, PH; Ravishankar, D; Salamah, M; Vaiyapuri, R; Vaiyapuri, S; Watson, KA; Williams, HF | 1 |
| Eid, AH; Giordo, R; Pintus, G; Zinellu, A | 1 |
| Du, X; Li, C; Li, W; Li, X; Qian, A; Sang, H; Sun, L; Zhang, Y | 1 |
| Amadio, P; Banfi, C; Barbieri, SS; Brioschi, M; Colombo, GI; Gianellini, S; Ieraci, A; Lee, FS; Parolari, A; Tarantino, E; Tremoli, E; Werba, JP | 1 |
| Cacciapuoti, F | 1 |
| Andriantsitohaina, R; Lagrue-Lak-Hal, AH | 1 |
| Akhmedov, A; Breitenstein, A; Camici, GG; Elliott, PJ; Holy, EW; Lohmann, C; Lüscher, TF; Matter, CM; Spescha, R; Stein, S; Tanner, FC; Westphal, CH | 1 |
| Garg, M; Lazarus, S; Phang, M; Wood, LG | 1 |
| Chu, LM; Lassaletta, AD; Robich, MP; Sellke, FW | 1 |
| Chen, YJ; Chow, SE; Wang, JS | 1 |
5 review(s) available for resveratrol and Blood Clot
| Article | Year |
|---|---|
Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders.
Topics: Anti-Inflammatory Agents; COVID-19 Drug Treatment; Endothelial Cells; Fibrinolytic Agents; Hemostasis; Hemostatic Disorders; Humans; Inflammation; Resveratrol; Thrombosis | 2021 |
Opposite effects of metabolic syndrome and calorie restriction on thrombotic disease: heads and tails of the same coin--resveratrol's role.
Topics: Animals; Blood Coagulation; Caloric Restriction; Fibrinolytic Agents; Humans; Metabolic Syndrome; Myocardial Ischemia; Resveratrol; Sirtuins; Stilbenes; Thrombosis; Ventricular Function, Left; Wine | 2009 |
Red wine and cardiovascular risks.
Topics: Alcohol Drinking; Animals; Aorta; Atherosclerosis; Cardiovascular Diseases; Color; Endothelium, Vascular; Flavonoids; Humans; Models, Animal; Phenols; Polyphenols; Resveratrol; Risk Assessment; Stilbenes; Thrombosis; Vascular Diseases; Vasodilator Agents; Wine | 2006 |
Diet and thrombosis risk: nutrients for prevention of thrombotic disease.
Topics: Alcohol Drinking; Allium; Diet; Dietary Carbohydrates; Dietary Fats; Fatty Acids; Fatty Acids, Omega-3; Fibrinolytic Agents; Flavonoids; Ginkgo biloba; Humans; Methionine; Phenols; Platelet Activation; Platelet Aggregation; Polyphenols; Receptors, Calcitriol; Resveratrol; Solanum lycopersicum; Stilbenes; Thrombosis; Vitamin B Complex; Vitamin E; Vitamin K; Zingiber officinale | 2011 |
Resveratrol in the prevention and treatment of coronary artery disease.
Topics: Animals; Cardiovascular System; Coronary Artery Disease; Humans; Lipid Peroxidation; Lipids; Macrophages; Metabolic Syndrome; Muscle, Smooth, Vascular; Myocardial Reperfusion; Plaque, Atherosclerotic; Resveratrol; Stilbenes; Thrombosis; Wine | 2011 |
10 other study(ies) available for resveratrol and Blood Clot
| Article | Year |
|---|---|
Polysulfated xanthones: multipathway development of a new generation of dual anticoagulant/antiplatelet agents.
Topics: Adult; Animals; Anticoagulants; Factor Xa Inhibitors; Glucosides; Humans; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Sulfuric Acid Esters; Thrombosis; Xanthones | 2011 |
3,5,2',4'-Tetramethoxystilbene, a fully methylated resveratrol analog, prevents platelet aggregation and thrombus formation by targeting the protease-activated receptor 4 pathway.
Topics: Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thrombin; Resveratrol; Thrombosis | 2022 |
Resveratrol Inhibits Metabolism and Affects Blood Platelet Function in Type 2 Diabetes.
Topics: Blood Platelets; Cardiovascular Diseases; Collagen; Diabetes Mellitus, Type 2; Humans; Platelet Aggregation; Resveratrol; Thrombosis; Thromboxane A2 | 2022 |
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency.
Topics: Animals; Genotype; Homocystinuria; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mice; Muscle Spasticity; Psychotic Disorders; Resveratrol; Sirtuin 1; Thrombosis | 2022 |
From resveratrol to ISIDE11: how to activate SIRT1 and improve endothelial function? New therapeutic insights for methylenetetrahydrofolate reductase deficiency.
Topics: Homocystinuria; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Muscle Spasticity; Psychotic Disorders; Resveratrol; Sirtuin 1; Thrombosis | 2022 |
Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Drug Evaluation, Preclinical; Female; Healthy Volunteers; Humans; Inhibitory Concentration 50; Male; Mice; Models, Animal; Molecular Docking Simulation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Purinergic P2Y12; Resveratrol; Signal Transduction; Stilbenes; Thrombosis | 2019 |
Resveratrol Improves Endothelial Progenitor Cell Function through miR-138 by Targeting Focal Adhesion Kinase (FAK) and Promotes Thrombus Resolution In Vivo.
Topics: Adult; Animals; Cell Movement; Endothelial Progenitor Cells; Focal Adhesion Protein-Tyrosine Kinases; Humans; Male; MicroRNAs; Neovascularization, Physiologic; Rats, Nude; Resveratrol; Stilbenes; Thrombosis; Up-Regulation | 2018 |
BDNFVal66met polymorphism: a potential bridge between depression and thrombosis.
Topics: Animals; Anxiety Disorders; Aorta; Blood Coagulation; Brain-Derived Neurotrophic Factor; Carotid Arteries; Carotid Artery Thrombosis; Depressive Disorder; Disease Models, Animal; Female; Heterozygote; Homozygote; Humans; Male; Mice, Transgenic; Middle Aged; Myocardial Ischemia; Nerve Tissue Proteins; Platelet Activation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Receptors, Cell Surface; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Thrombosis | 2017 |
Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
Topics: Animals; Benzamides; Binding Sites; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activators; Genes, Reporter; Histone Deacetylase Inhibitors; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Naphthalenes; Naphthols; Promoter Regions, Genetic; Pyrones; Resveratrol; RNA Interference; RNA, Messenger; Sirtuin 1; Stilbenes; Thromboplastin; Thrombosis; Transcription Factor RelA; Transfection | 2011 |
Resveratrol protects vascular endothelial cell from ox-LDL-induced reduction in antithrombogenic activity.
Topics: Antioxidants; Blood Platelets; Calcium; Cells, Cultured; Coculture Techniques; Cyclic GMP; Endothelial Cells; Humans; Intracellular Membranes; Lipoproteins, LDL; Nitric Oxide; Nitric Oxide Synthase Type III; Osmolar Concentration; Platelet Aggregation; Resveratrol; Stilbenes; Thrombosis | 2007 |